vCJD poses greatest threat to blood bank
Variant Creutzfeldt-Jacob disease (vCJD), a rare and fatal neuro-degenerative condition that may be transmissible through blood, poses the biggest challenge facing the IBTS, its chief executive Andrew Kelly told a health conference in Dublin yesterday.
While a series of measures have been taken to prevent vCJD from entering the blood supply, the problem was there was no test for the disease, Mr Kelly told a conference hosted by nine key health services organisations.



